Eicosapentaenoic acid reduces ischemic ventricular fibrillation via altering monophasic action potential in pigs

Journal of Molecular and Cellular Cardiology

Volumn 51, Issue 3, 2011, Pages 329-336

  Tsuburaya, Ryuji ^a   Yasuda, Satoshi ^a   Ito, Yoshitaka ^a   Shiroto, Takashi ^a   Gao, Jun Yi ^a   Ito, Kenta ^a   Shimokawa, Hiroaki ^a  

^a TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Fish oils; Ischemia; K ATP channel; Sudden death; Ventricular arrhythmias

Indexed keywords

CROMAKALIM; ICOSAPENTAENOIC ACID; INWARDLY RECTIFYING POTASSIUM CHANNEL SUBUNIT KIR6.2; MESSENGER RNA;

ACTION POTENTIAL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; FATTY ACID ANALYSIS; HEART MUSCLE ISCHEMIA; HEART VENTRICLE FIBRILLATION; IN VIVO STUDY; MALE; MORTALITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SWINE;

ACTION POTENTIALS; ANIMALS; ANTI-ARRHYTHMIA AGENTS; CROMAKALIM; DISEASE MODELS, ANIMAL; EICOSAPENTAENOIC ACID; FATTY ACIDS; GENE EXPRESSION REGULATION; MALE; MYOCARDIAL ISCHEMIA; PARASYMPATHOLYTICS; POTASSIUM CHANNELS, INWARDLY RECTIFYING; SWINE; VENTRICULAR FIBRILLATION;

SUIDAE;

EID: 79960895693     PISSN: 00222828     EISSN: 10958584     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2011.05.018     Document Type: Article

References (50)

1. Lowel H., Dobson A., Keil U., Herman B., Hobbs M.S., Stewart A., et al. Coronary heart disease case fatality in four countries. A community study. The Acute Myocardial Infarction Register Teams of Auckland, Augsburg, Bremen, FINMONICA, Newcastle, and Perth. Circulation 1993, 88:2524-2531.
2. O'Doherty M., Tayler D.I., Quinn E., Vincent R., Chamberlain D.A. Five hundred patients with myocardial infarction monitored within one hour of symptoms. Br Med J (Clin Res Ed) 1983, 286:1405-1408.
3. Bang H.O., Dyerberg J., Hjoorne N. The composition of food consumed by Greenland Eskimos. Acta Med Scand 1976, 200:69-73.
4. Albert C.M., Campos H., Stampfer M.J., Ridker P.M., Manson J.E., Willett W.C., et al. Blood levels of long-chain n-3 fatty acids and the risk of sudden death. N Engl J Med 2002, 346:1113-1118.
5. Burr M.L., Fehily A.M., Gilbert J.F., Rogers S., Holliday R.M., Sweetnam P.M., et al. Effects of changes in fat, fish, and fibre intakes on death and myocardial reinfarction: diet and reinfarction trial (DART). Lancet 1989, 2:757-761.
6. Leaf A., Albert C.M., Josephson M., Steinhaus D., Kluger J., Kang J.X., et al. Prevention of fatal arrhythmias in high-risk subjects by fish oil n-3 fatty acid intake. Circulation 2005, 112:2762-2768.
7. Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico. Lancet 1999, 354:447-455. GISSI-Prevenzione Investigators.
8. + loss during hypoxia, ischemia, and metabolic inhibition in mammalian ventricle. Circ Res 1991, 69:623-637.
9. Chi L., Uprichard A.C., Lucchesi B.R. Profibrillatory actions of pinacidil in a conscious canine model of sudden coronary death. J Cardiovasc Pharmacol 1990, 15:452-464.
10. 14C]eicosapentaenoic acid by human platelets. Thromb Res 1982, 28:285-298.
11. Matsumoto M., Sata M., Fukuda D., Tanaka K., Soma M., Hirata Y., et al. Orally administered eicosapentaenoic acid reduces and stabilizes atherosclerotic lesions in ApoE-deficient mice. Atherosclerosis 2008, 197:524-533.
12. Tagawa H., Shimokawa H., Tagawa T., Kuroiwa-Matsumoto M., Hirooka Y., Takeshita A. Long-term treatment with eicosapentaenoic acid augments both nitric oxide-mediated and non-nitric oxide-mediated endothelium-dependent forearm vasodilatation in patients with coronary artery disease. J Cardiovasc Pharmacol 1999, 33:633-640.
13. Leaf A., Kang J.X., Xiao Y.F., Billman G.E. Clinical prevention of sudden cardiac death by n-3 polyunsaturated fatty acids and mechanism of prevention of arrhythmias by n-3 fish oils. Circulation 2003, 107:2646-2652.
14. Ogita H., Node K., Asanuma H., Sanada S., Takashima S., Minamino T., et al. Eicosapentaenoic acid reduces myocardial injury induced by ischemia and reperfusion in rabbit hearts. J Cardiovasc Pharmacol 2003, 41:964-969.
15. Franz M.R. Long-term recording of monophasic action potentials from human endocardium. Am J Cardiol 1983, 51:1629-1634.
16. Sheehan F.H., Bolson E.L., Dodge H.T., Mathey D.G., Schofer J., Woo H.W. Advantages and applications of the centerline method for characterizing regional ventricular function. Circulation 1986, 74:293-305.
17. Osaka T., Yokoyama E., Kushiyama Y., Hasebe H., Kuroda Y., Suzuki T., et al. Opposing effects of bepridil on ventricular repolarization in humans. Inhomogeneous prolongation of the action potential duration vs flattening of its restitution kinetics. Circ J 2009, 73:1612-1618.
18. Levine J.H., Moore E.N., Kadish A.H., Guarnieri T., Spear J.F. The monophasic action potential upstroke: a means of characterizing local conduction. Circulation 1986, 74:1147-1155.
19. + channels in isolated cardiac myocytes. Biochem Biophys Res Commun 1988, 154:620-625.
20. ATP channel by glyburide and 5-hydroxydecanoate. J Biol Chem 1998, 273:13578-13582.
21. ATP opener cromakalim is not correlated with ischemic myocardial action potential duration. J Cardiovasc Pharmacol 1995, 26:145-152.
22. Sanada S., Kitakaze M., Asanuma H., Harada K., Ogita H., Node K., et al. Role of mitochondrial and sarcolemmal K(ATP) channels in ischemic preconditioning of the canine heart. Am J Physiol Heart Circ Physiol 2001, 280:H256-H263.
23. ATP channels in pig and human intracranial arteries. Eur J Pharmacol 2008, 601:43-49.
24. + channel pore 6.1/sulfonylurea receptor 2A in pig detrusor smooth muscle cells: uncoupling of cAMP signal pathways. J Pharmacol Exp Ther 2008, 327:114-123.
25. Leon H., Shibata M.C., Sivakumaran S., Dorgan M., Chatterley T., Tsuyuki R.T. Effect of fish oil on arrhythmias and mortality: systematic review. BMJ 2008, 337:a2931.
26. Mori T.A., Burke V., Puddey I.B., Watts G.F., O'Neal D.N., Best J.D., et al. Purified eicosapentaenoic and docosahexaenoic acids have differential effects on serum lipids and lipoproteins, LDL particle size, glucose, and insulin in mildly hyperlipidemic men. Am J Clin Nutr 2000, 71:1085-1094.
27. Coronel R., Wilms-Schopman F.J., Den Ruijter H.M., Belterman C.N., Schumacher C.A., Opthof T., et al. Dietary n-3 fatty acids promote arrhythmias during acute regional myocardial ischemia in isolated pig hearts. Cardiovasc Res 2007, 73:386-394.
28. Billman G.E., Hallaq H., Leaf A. Prevention of ischemia-induced ventricular fibrillation by omega 3 fatty acids. Proc Natl Acad Sci USA 1994, 91:4427-4430.
29. Kinoshita I., Itoh K., Nishida-Nakai M., Hirota H., Otsuji S., Shibata N. Antiarrhythmic effects of eicosapentaenoic acid during myocardial infarction-enhanced cardiac microsomal (Ca2+-Mg2+)-ATPase activity. Jpn Circ J 1994, 58:903-912.
30. Verkerk A.O., van Ginneken A.C., Berecki G., den Ruijter H.M., Schumacher C.A., Veldkamp M.W., et al. Incorporated sarcolemmal fish oil fatty acids shorten pig ventricular action potentials. Cardiovasc Res 2006, 70:509-520.
31. Kang J.X., Xiao Y.F., Leaf A. Free, long-chain, polyunsaturated fatty acids reduce membrane electrical excitability in neonatal rat cardiac myocytes. Proc Natl Acad Sci USA 1995, 92:3997-4001.
32. Franz M.R., Burkhoff D., Spurgeon H., Weisfeldt M.L., Lakatta E.G. In vitro validation of a new cardiac catheter technique for recording monophasic action potentials. Eur Heart J 1986, 7:34-41.
33. Franz M.R. Current status of monophasic action potential recording: theories, measurements and interpretations. Cardiovasc Res 1999, 41:25-40.
34. Taggart P., Sutton P.M., Boyett M.R., Lab M., Swanton H. Human ventricular action potential duration during short and long cycles. Rapid modulation by ischemia. Circulation 1996, 94:2526-2534.
35. Wirth K.J., Uhde J., Rosenstein B., Englert H.C., Gogelein H., Scholkens B.A., et al. K(ATP) channel blocker HMR 1883 reduces monophasic action potential shortening during coronary ischemia in anesthetised pigs. Naunyn Schmiedebergs Arch Pharmacol 2000, 361:155-160.
36. Geelen P., O'Hara G.E., Plante S., Philippon F., Gilbert M., Turgeon J. Ischemia-induced action potential shortening is blunted by d-sotalol in a pig model of reversible myocardial ischemia. J Cardiovasc Pharmacol 2000, 35:638-645.
37. Reibel D.K., Holahan M.A., Hock C.E. Effects of dietary fish oil on cardiac responsiveness to adrenoceptor stimulation. Am J Physiol 1988, 254:H494-H499.
38. Mozaffarian D., Geelen A., Brouwer I.A., Geleijnse J.M., Zock P.L., Katan M.B. Effect of fish oil on heart rate in humans: a meta-analysis of randomized controlled trials. Circulation 2005, 112:1945-1952.
39. Gasser R.N., Vaughan-Jones R.D. Mechanism of potassium efflux and action potential shortening during ischaemia in isolated mammalian cardiac muscle. J Physiol 1990, 431:713-741.
40. Vajda S., Baczko I., Lepran I. Selective cardiac plasma-membrane K(ATP) channel inhibition is defibrillatory and improves survival during acute myocardial ischemia and reperfusion. Eur J Pharmacol 2007, 577:115-123.
41. ATP channels and may increase propensity for ischemic ventricular fibrillation in pigs. Diabetologia 2008, 51:675-685.
42. del Valle H.F., Lascano E.C., Negroni J.A., Crottogini A.J. Glibenclamide effects on reperfusion-induced malignant arrhythmias and left ventricular mechanical recovery from stunning in conscious sheep. Cardiovasc Res 2001, 50:474-485.
43. + channels. Neuron 1996, 16:1011-1017.
44. Moreau C., Jacquet H., Prost A.L., D'Hahan N., Vivaudou M. The molecular basis of the specificity of action of K(ATP) channel openers. EMBO J 2000, 19:6644-6651.
45. + channel. J Physiol 1997, 499(Pt 3):715-720.
46. + channels in mitochondria. Biochem Biophys Res Commun 1997, 241:693-697.
47. Liu Y., Ren G., O'Rourke B., Marban E., Seharaseyon J. Pharmacological comparison of native mitochondrial K(ATP) channels with molecularly defined surface K(ATP) channels. Mol Pharmacol 2001, 59:225-230.
48. Engler M.B., Engler M.M., Browne A., Sun Y.P., Sievers R. Mechanisms of vasorelaxation induced by eicosapentaenoic acid (20:5n-3) in WKY rat aorta. Br J Pharmacol 2000, 131:1793-1799.
49. Matsuzaki M., Yokoyama M., Saito Y., Origasa H., Ishikawa Y., Oikawa S., et al. Incremental effects of eicosapentaenoic acid on cardiovascular events in statin-treated patients with coronary artery disease. Circ J 2009, 73:1283-1290.
50. Schouten V.J. The negative correlation between action potential duration and force of contraction during restitution in rat myocardium. J Mol Cell Cardiol 1986, 18:1033-1045.